Desipramine (Pertofrane)

641  relevant articles (56 outcomes, 105 trials/studies) found for this Drug

Pertofrane; Norpramin; Apo-Desipramine; Apotex Brand of Desipramine Hydrochloride; Aventis Behring Brand of Desipramine Hydrochloride; Aventis Brand of Desipramine Hydrochloride; Demethylimipramine; Desipramine Hydrochloride; Novartis Brand of Desipramine Hydrochloride; Novo-Desipramine; Novopharm Brand of Desipramine Hydrochloride; Nu-Desipramine; Nu-Pharm Brand of Desipramine Hydrochloride; PMS-Desipramine; Pertofran; Pertrofran; Petylyl; Pharmascience Brand of Desipramine Hydrochloride; Ratiopharm Brand of Desipramine Hydrochloride; Rhône-Poulenc Rorer Brand of Desipramine Hydrochloride; Temmler Brand of Desipramine Hydrochloride; ratio-Desipramine; Hydrochloride, Desipramine; Nu Pharm Brand of Desipramine Hydrochloride; Rhône Poulenc Rorer Brand of Desipramine Hydrochloride; Desmethylimipramine; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-

Relationship Network

Drug Context: Research Results

Experts

1.	Jan, Chung-Ren: 3 articles (08/2008 - 12/2003)
2.	Oliveto, Alison: 3 articles (01/2005 - 06/2003)
3.	Gonsai, Kishor: 3 articles (01/2005 - 06/2003)
4.	Chou, Chiang-Ting: 2 articles (08/2008 - 04/2007)
5.	Huang, Chun-Jen: 2 articles (08/2008 - 04/2007)
6.	Chang, Hong-Tai: 2 articles (08/2008 - 12/2003)
7.	Huang, Jong-Khing: 2 articles (08/2008 - 12/2003)
8.	Wang, Jue-Long: 2 articles (04/2007 - 12/2003)
9.	Lu, Yih-Chau: 2 articles (04/2007 - 12/2003)
10.	Tseng, Li-Ling: 2 articles (04/2007 - 12/2003)

Related Diseases

1.	Pain (Aches) 03/01/1990 - "Pain relief with desipramine was statistically significant from weeks 3 to 6. Psychiatric interview at entry into the study produced a diagnosis of depression for 4 patients; pain relief was similar in depressed and nondepressed patients and was statistically significant in the nondepressed group alone" 03/01/1990 - "Desipramine has the least anticholinergic and sedative effects of the first generation tricyclic antidepressant agents, but its pain-relieving potential has received little study" 11/01/2005 - "All 3 drugs reduced PHN pain, with desipramine providing satisfactory relief in 80% of those treated." 11/01/1992 - "The mean increase in peak VAS relief score after desipramine pretreatment, relative to placebo, was 6%; the 95% confidence interval for this estimate ranged from a 21% reduction to a 34% increase in pain relief" 11/01/1992 - "In a two-by-two factorial design, we randomized 62 inpatients with pain following major surgery to receive either desipramine, 50 mg by mouth, or placebo at 6 a.m" Get all the results and reference details, order at left...
2.	Cocaine-Related Disorders (Cocaine Addiction) 01/01/1984 - "Desipramine was compared with a placebo under double-blind conditions to determine if it is effective treatment for withdrawal from cocaine dependence" 12/01/1991 - "Using the technique of meta-analysis, we compared and combined the data from six studies to examine the efficacy of desipramine as an adjunctive treatment approach for cocaine addiction" 03/01/2003 - "This finding supports previous reports of a possible role for desipramine in cocaine abuse treatment." 09/01/2000 - "Conversely, uptake inhibitors, such as the tricyclic antidepressant, desipramine, and the drug of abuse, cocaine, inhibit noradrenergic differentiation in both tissues" 03/01/1994 - "Desipramine treatment for cocaine dependence" Get all the results and reference details, order at left...
3.	Panic Disorder (Panic Attack) 12/01/1985 - "Independent of DSM-III diagnosis, however, evidence of panic attacks seemed to identify patients who benefited from desipramine therapy" 01/01/1987 - "Preliminary results of an open, fixed-dose study of desipramine in panic disorder." 03/01/1995 - "Desipramine plasma levels and treatment response in panic disorder." 01/01/1993 - "Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder." 04/01/1991 - "Desipramine treatment in panic disorder." Get all the results and reference details, order at left...
4.	Major Depressive Disorder (Major Depressive Disorders) 12/01/1996 - "Thirty-six outpatients aged 20 to 51 with RDC primary major depressive disorder (MDD) completed a 5-week trial of desipramine following a week of single-blind placebo" 10/01/1994 - "Thirty-seven patients who fulfilled DSM-III-R criteria for Major Depressive Disorder were recruited for a double-blind controlled trial of Desipramine and placebo for 6 weeks" 01/01/1991 - "Thirty adolescents (ages 15-20) who met DSM-III-R criteria for major depressive disorder completed a double-blind, placebo-controlled, 6-week, fixed-dose (200 mg daily) study of desipramine (DMI)" 01/01/1995 - "To evaluate NK activity changes associated with both the diagnosis of major depressive disorder (MDD) and the in vivo treatment of MDD with the tricyclic antidepressant desmethylimipramine (DMI), 15 MDD outpatients (11 females, four males) and eight controls (six females, two males) were evaluated prospectively at intake and after an average of 12 weeks of standardized DMI treatment" 06/01/1994 - "OBJECTIVE: To determine the efficacy and tolerability of the tricyclic antidepressant desipramine (DMI) in the treatment of DSM-III-R-diagnosed major depressive disorder in adolescents" Get all the results and reference details, order at left...
5.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/01/1989 - "In a 6-week study of children and adolescents with attention deficit disorder with hyperactivity (ADDH) in which desipramine (DMI) was highly effective and well tolerated, the mean maximal daily oral dose in the DMI-treated patients (N = 31) was 4.6 +/- 0.2 mg/kg. Additional data were obtained for 27 placebo nonresponders given DMI openly for 6 additional weeks following a nearly identical protocol and mean daily doses (total N = 58)" 06/01/1991 - "Desipramine is a tricyclic antidepressant with demonstrated efficacy for some children with attention deficit hyperactivity disorder (ADHD)" 09/01/1996 - "Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder." 01/01/1993 - "A 6-week randomized, double-blind, placebo controlled trial of desipramine (DMI) in daily doses averaging 4 to 5 mg/kg for the treatment of children and adolescents with attention deficit disorder with hyperactivity (ADDH) was further analyzed" 12/01/1986 - "Eighteen children with attention deficit disorder were treated with desipramine in a prospective open trial to assess its efficacy and safety" Get all the results and reference details, order at left...
203 Diseases and 641 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Amitriptyline (Elavil)
2.	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
3.	Clomipramine (Anafranil)
4.	Imipramine (Janimine)
5.	Nortriptyline (Aventyl)
6.	Fluoxetine (Prozac)
7.	Methadone (Dolophine)
8.	Cocaine (Cocaine HCl)
9.	Norepinephrine (Noradrenaline)
10.	Serotonin (5 Hydroxytryptamine)
524 Drugs and Important Bio-Agents and 470 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Analgesia
2.	Ligation
3.	Induced Hypothermia
4.	Aftercare (After-Treatment)
5.	Drug Therapy (Chemotherapy)
8 Therapies and Procedures and 18 more articles analyzed in the Research Interface, order at left...